Parkinson’s Disease

Editorial Board

Academic Editors

  • Jan Aasly , Norwegian University of Science and Technology, Norway
  • Cristine Alves da Costa , Centre National de la Research Scientifique, France
  • Ivan Bodis-Wollner, SUNY Downstate Medical Center, USA
  • Carlo Colosimo, Santa Maria University Hospital, Italy
  • Seyed-Mohammad Fereshtehnejad , Karolinska Institute, Sweden
  • Carlo Ferrarese , University of Milano-Bicocca, Italy
  • Francisco Grandas , Hospital General Universitario Gregorio Marañón, Spain
  • Peter Hagell , Kristianstad University, Sweden
  • Nobutaka Hattori , Juntendo University, Japan
  • Marjan Jahanshahi , UCL Institute of Neurology, United Kingdom
  • Graziella Madeo , National Institutes of Health, USA
  • Giuseppina Martella , Università degli Studi di Roma Tor Vergata, Italy
  • Pablo Mir , Universidad de Sevilla, Spain
  • Giovanni Mirabella , La Sapienza University, Italy
  • Antonio Pisani , University of Rome Tor Vergata, Italy
  • Fabrizio Stocchi, IRCCS San Raffaele, Italy
  • Stefano Tamburin , University of Verona, Italy
  • Eng King Tan , National Neuroscience Institute, Singapore
  • Hélio Teive , Federal University of Paraná, Brazil
  • Karsten Witt , Carl von Ossietzky Universität Oldenburg, Germany
    Parkinson’s Disease
     Journal metrics
    Acceptance rate51%
    Submission to final decision75 days
    Acceptance to publication35 days
    Impact Factor1.758

    We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.